Please login to the form below

Not currently logged in
Email:
Password:

Sudler & Hennessey cofounder dies

Matt Hennessey, one of Sudler & Hennessey's (S&H) cofounders has died of cancer at the age of 95

Matt Hennessey, one of Sudler & Hennessey's (S&H) cofounders has died of cancer at the age of 95.

Matthew Joseph Hennessey was born in 1916, in Brooklyn, New York. Hennessey began his art career in 1936, working with Arthur Sudler in his graphic design studio where Sudler set up shop with E R Squibb and Sons as his charter client. Five years later, they founded Sudler & Hennessey, with Hennessey as president and Sudler as chairman.

Art directors hired by Hennessey included George Lois, Helmut Krone, Ernie Smith, Herb Lubalin, Charles Addams, Ronald Searle, and Andy Warhol.

Hennessey was a believer in the power of visual communication, and it was at the helm when the original NBC peacock was created by S&H.

After serving in the army during World War II, Hennessey returned to the agency and, in 1953, made the decision to focus on the pharmaceutical industry. By 1968, S&H was the largest medical agency and held that distinction for more than 20 years.

After Art Sudler passed away, Sudler & Hennessey became part of Young & Rubicam, now with a network that spans the globe. Hennessey was inducted into the Medical Advertising Hall of Fame in 1998.

Jed Beitler, chairman and CEO worldwide, S&H, said: "Matt retired in 1984, but his legacy to the business world lives on. His vision helped to lay the foundation for the success S&H enjoys today on a global scale."

26th April 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics